Showing results (71-80 of 81) with videos related to
Sort By:
Pageof 9
Neuropharmacology|December 5, 2025
Antisense oligonucleotide of cargo adaptor BICD2 long-term effectively alleviates neuropathic pain via activation of PSD95 in the mouse spinal dorsal hornZi-Xuan Wu, Yang Xu, Jing Xie, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|November 19, 2025
Histone Lactylation Contributes to Neuropathic Pain by Facilitating m6A Reader Protein IGF2BP2 Expression in DRG Sensory NeuronsQi-Hui Wang, Shan Xie, Ke-Hui Yang, et al.Carcinogenesis|February 13, 2018
MiR-134, epigenetically silenced in gliomas, could mitigate the malignant phenotype by targeting KRASZhi-Liang Wang, Chuan-Bao Zhang, Zheng Wang, et al.The Journal of Clinical Investigation|February 16, 2026
Hyperactivation of mTORC1 signaling mediates folliculin deficiency-induced pulmonary cyst formation in Birt-Hogg-Dubé syndromeKe Cao, Hui Chen, Ling Chu, et al.Molecular Neurobiology|June 12, 2024
Kv3.1 Interaction with UBR5 Is Required for Chronic Inflammatory PainYing Zeng, Meng-Lan Sun, Di Liu, et al.Proceedings of the National Academy of Sciences of the United States of America|February 8, 2013
Association of functional nucleotide polymorphisms at DTH2 with the northward expansion of rice cultivation in AsiaWeixun Wu, Xiao-Ming Zheng, Guangwen Lu, et al.Pain|August 25, 2023
DNA N6-methyladenine methylase N6AMT1 controls neuropathic pain through epigenetically modifying Kcnj16 in dorsal horn neuronsHui-Min Zhou, Heng-Jun Xu, Run-Hang Sun, et al.Journal for Immunotherapy of Cancer|October 20, 2021
MET overexpression contributes to STAT4-PD-L1 signaling activation associated with tumor-associated, macrophages-mediated immunosuppression in primary glioblastomasQiang-Wei Wang, Li-Hua Sun, Ying Zhang, et al.Acta Pharmacologica Sinica|April 24, 2023
DHX9/DNA-tandem repeat-dependent downregulation of ciRNA-Fmn1 in the dorsal horn is required for neuropathic painXiao-Dan Liu, Tong Jin, Yang Tao, et al.Journal of Medicinal Chemistry|September 13, 2022
Developing HDAC4-Selective Protein Degraders To Investigate the Role of HDAC4 in Huntington's Disease PathologyNatsuko Macabuag, William Esmieu, Perla Breccia, et al.Pageof 9